This article compares two approaches side by side to clarify how they differ in principle and practice. Deep vein thrombosis is the formation of a blood clot within the deep veins, most often in the legs, and it can cause pain, swelling, and — if a fragment travels to the lungs — pulmonary embolism. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Deep Vein Thrombosis (DVT)
Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. Whether an interventional approach is appropriate is a clinical decision that weighs clot age, location, bleeding risk, and overall condition. Techniques include mechanical thrombectomy, aspiration thrombectomy, and pharmacomechanical approaches that combine device action with a clot-dissolving drug.
Catheter-directed thrombolysis vs Mechanical thrombectomy: Key Differences
Catheter-directed thrombolysis concentrates a drug within the clot but needs an infusion period; mechanical thrombectomy provides more immediate debulking. CDT can be gentler on organized clot but carries drug-related bleeding risk; mechanical methods reduce drug exposure but instrument the vein. Combined pharmacomechanical techniques try to capture the benefits of both. Bleeding risk assessment drives which pathway a clinician selects.
How INVAMED Supports Both Approaches
INVAMED's Mantis platform is organized by the mechanism used to engage and remove venous clot, alongside protective and access tools. INVAMED positions the Mantis family as a modular thrombectomy platform covering rotational, aspiration, and pharmacomechanical mechanisms. Catheter French sizes and working lengths are specified in product documentation; buyers should confirm local registration status.
Key Considerations
- Manufacturer performance descriptions reflect device design goals rather than guaranteed individual outcomes.
- Retrievable IVC filters are intended to be removed once protection is no longer needed, per current guidance.
- Clot age and location strongly influence which mechanism — aspiration, rotation, or pharmacomechanical — is most suitable.
Frequently Asked Questions
Does thrombectomy replace blood thinners?
No. Catheter thrombectomy removes existing clot but is generally used alongside anticoagulation, not as a replacement; management is individualized.
Can thrombectomy be done in one session?
Mechanical thrombectomy is often designed to restore flow in a single session where feasible, but this depends on the clot and is judged by the operator.
Is the MultiBEAM IVC filter retrievable?
Yes. INVAMED describes MultiBEAM as a retrievable IVC filter, designed to be removed once the risk of pulmonary embolism has passed.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
INVAMED's Mantis AspireJET and Dovi ultra-aspiration catheter are positioned for high-vacuum clot removal. CDT is typically reserved for selected patients after careful bleeding-risk evaluation. INVAMED's Viper ULTRA thrombolysis catheter is designed for this localized infusion role. Clot age and location strongly influence which mechanism — aspiration, rotation, or pharmacomechanical — is most suitable. Device choice within a mechanical approach depends on clot location, chronicity, and vessel size. Standard care starts with anticoagulation (blood thinners), but selected patients with large, symptomatic, or limb-threatening clot burden may be considered for catheter-based clot removal. Techniques include mechanical thrombectomy, aspiration thrombectomy, and pharmacomechanical approaches that combine device action with a clot-dissolving drug. Retrievable filters are intended to avoid the long-term risks associated with permanently implanted filters. Effective aspiration depends on matching catheter bore to the target vessel and clot burden. Left untreated, extensive iliofemoral DVT is associated with a higher risk of long-term complications such as post-thrombotic syndrome, marked by chronic swelling and discomfort. Deep vein thrombosis is the formation of a blood clot within the deep veins, most often in the legs, and it can cause pain, swelling, and — if a fragment travels to the lungs — pulmonary embolism. Use of any thrombolytic is governed by bleeding-risk assessment performed by the clinician.
Important Disclaimer
This article is intended for general educational and technical information about medical device technologies. It is not medical advice, a diagnosis, or a treatment recommendation, and it does not replace consultation with a qualified healthcare professional. Any decision about diagnosis or treatment should be made by a licensed clinician based on an individual assessment. INVAMED devices are intended for use by trained healthcare professionals in accordance with the applicable Instructions for Use (IFU) and local regulatory approvals. Product availability and indications vary by country.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.